Mather Group’s Dare Bioscience DARE Stock Holding History

Mather Group’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$72	Hold	84	–	–	﹤0.01%	2225
2026 Q2	$177	Sell	84 -1	-1%	-$2	﹤0.01%	1867
2026 Q1	$155	Buy	+85	New	+$145	﹤0.01%	1856
2025 Q4	–	Sell	-84	Closed	-$176	–	884
2025 Q3	$176	Buy	+84	New	+$189	﹤0.01%	1667
2025 Q2	–	Sell	-84	Closed	-$243	–	875
2025 Q1	$243	Hold	84	–	–	﹤0.01%	1719
2024 Q4	$262	Hold	84	–	–	﹤0.01%	1687
2024 Q3	$272	Buy	84 +1	+1%	+$3	﹤0.01%	1644
2024 Q2	$490	Buy	+83	New	+$402	﹤0.01%	2074

Other funds holding DARE

US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Garde Capital Seattle, Washington $1.8B AUM 11.9% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

IFS Advisors Overland Park, Kansas $332M AUM 8.56% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Entrust Financial Wayne, Pennsylvania $205M AUM 12.8% 1-Year Est. Return

Jacobi Capital Management Pittston, Pennsylvania $2.11B AUM 19.6% 1-Year Est. Return

Mather Group's DARE Position: Q3 2026 in Review

Mather Group held its Dare Bioscience (DARE) position steady in Q3 2026 at 84 shares worth $72. The position accounts for ﹤0.01% of the portfolio, ranked #2225.

Mather Group first reported a position in DARE in Q2 2024 and has held it in 8 quarters since. The position peaked at $490 in Q2 2024. 15 funds tracked by Wall St. Rank hold DARE as of Q3 2026.

Mather Group held 84 shares of Dare Bioscience worth $72 as of Q3 2026.
Mather Group left its Dare Bioscience share count unchanged in Q3 2026.
Dare Bioscience made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #2225 holding.
Mather Group first reported a position in Dare Bioscience in Q2 2024 and has held it in 8 quarters since.
Mather Group's Dare Bioscience position peaked at $490 in Q2 2024.
15 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.